The progression of hepatorenal syndrome-acute kidney injury in acute alcohol-associated hepatitis: renal outcomes after liver transplant

被引:0
|
作者
Colletta, Alessandro [1 ]
Cooper, Katherine M. [2 ]
Devuni, Deepika [3 ]
机构
[1] UMass Chan Med Sch, 55 Lake Ave North, Worcester, MA 01655 USA
[2] UMass Chan Med Sch, Worcester, MA USA
[3] UMass Chan Med Sch, Div Gastroenterol, Worcester, MA USA
关键词
acute alcohol-associated hepatitis; chronic liver disease; hepatorenal syndrome-acute kidney injury; inflammation; liver transplantation; patient outcomes; renal replacement therapy; CIRRHOSIS; TRANSFUSION; MODEL;
D O I
10.1177/17562848231188813
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Hepatorenal syndrome-acute kidney injury (HRS-AKI) is a complication of advanced liver disease in patients with ascites and circulatory dysfunction. Little data remain on the relationship between HRS-AKI outcomes and different etiologies of liver disease post-liver transplant (LT). Objectives:The primary aim was to evaluate the effect of HRS-AKI on renal outcomes in patients with acute alcohol-associated hepatitis (AAH) compared to chronic liver disease (CLD) after LT. The secondary aim was to evaluate the impact of acuity and chronicity of alcohol-associated liver disease in patients with HRS-AKI post-LT renal outcomes. Design:A retrospective observational study of patients undergoing urgent inpatient liver transplant evaluation (LTE) for cirrhosis and AAH at single academic LT center between October 2017 and July 2021 was conducted. Methods:Patients with HRS-AKI were selected based on indication for LTE: acute AAH(HRS) or CLDHRS. CLDHRS was categorized by disease etiology: cirrhosis due to alcohol (A-CLDHRS) versus cirrhosis from other causes (O-CLDHRS). CLD patients without HRS-AKI were labeled CLDno HRS. Results:A total of 210 subjects underwent LTE; 25% were evaluated for AAH and 75% were evaluated for CLD. Hepatorenal syndrome was more common in subjects evaluated for AAH (37/47) than CLD (104/163) (78.7 versus 63.8%, p = 0.04). For the primary outcome, AAH(HRS) subjects required & GT;30 days post-LT renal replacement therapy (RRT) more often than subjects with CLDHRS (p = 0.02) and CLDno HRS (p < 0.01). There was no significant difference in other forms of long-term renal outcomes including kidney transplant referral and kidney transplant among cohorts. In subgroup analysis, 30-days post-LT RRT was more common in AAH(HRS) than in A-CLDHRS (p = 0.08). Logistic regression showed that AAH(HRS) conferred a 20x and 3.3x odds of requiring & GT;30 days post-LT RRT compared to CLDno HRS and CLDHRS, respectively. Postoperative complications were similar across cohorts, but had a significant effect on 30-day renal outcome post-LT. Conclusions:Patients with AAH were more likely to develop HRS and require RRT pre- and post-LT at our center. The etiology of hepatic decompensation and postoperative complications affect renal recovery post-LT. The systemic inflammation of AAH in addition to conditions favoring renal hypoperfusion may contribute to the unfavorable outcomes of HRS-AKI after LT in this patient population.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Hepatorenal Syndrome-Acute Kidney Injury Definition Needs a Minimum Threshold for Serum Creatinine
    Thuluvath, Paul J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (02) : 435 - 436
  • [22] Defining Renal Recovery in Patients With Hepatorenal Syndrome-Acute Kidney Injury: Experience From North American Studies
    Mujtaba, Muhammad A.
    Elsiesy, Hussien
    Faiz, Sara
    Hussain, Syed A.
    Gamilla-Crudo, Ann Kathleen N.
    Karim, Aftab
    Khan, Mohammad Irfan
    Khattak, Muhammad Waqar
    Zafar, Zunaira
    Kueht, Michael
    Jamil, Khurram
    JGH OPEN, 2024, 8 (12):
  • [23] Novel predictors of response to therapy with terlipressin and albumin in hepatorenal syndrome-acute kidney injury
    Narayanan, Vijay
    Devadas, Krishnadas
    Sreesh, Srijaya
    Varghese, Jijo
    Solanki, Rushil
    Mohapatra, Shivabrata Dhal
    Pal, Ravindra
    Madhu, Devika
    Chakravorty, Avisek
    ANNALS OF GASTROENTEROLOGY, 2024, 37 (01): : 81 - 88
  • [24] Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)
    Kulkarni, Anand V.
    Lee, Jason
    Reddy, K. Rajender
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (11) : 1067 - 1079
  • [25] The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin
    Flamm, Steven L.
    Brown, Kimberly
    Wadei, Hani M.
    Brown, Robert S., Jr.
    Kugelmas, Marcelo
    Samaniego-Picota, Milagros
    Burra, Patrizia
    Poordad, Fred
    Saab, Sammy
    LIVER TRANSPLANTATION, 2021, 27 (08) : 1191 - 1202
  • [26] Prediction models combining zonulin, LPS, and LBP predict acute kidney injury and hepatorenal syndrome-acute kidney injury in cirrhotic patients
    Lin, Yi-Hsuan
    Kuo, Nai-Rong
    Shen, Hsiao-Chin
    Chang, Yun-Chien
    Lin, Roger
    Liao, Tsai-Ling
    Yeh, Hsiao-Yun
    Yang, Ying-Ying
    Hou, Ming-Chih
    Lin, Han-Chieh
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [27] OUTCOMES OF LIVER TRANSPLANTION IN SEVERE ACUTE ALCOHOLICASSOCIATED HEPATITIS AND ALCOHOL-ASSOCIATED CIRRHOSIS AT THE UNIVERSITY OF UTAH TRANSPLANT CENTER
    McDaniel, Charles W.
    Ofori-Atta, Blessing
    Kim, Rebecca G.
    Gallegos-Orozco, Juan F.
    GASTROENTEROLOGY, 2024, 166 (05) : S1750 - S1750
  • [28] Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome
    Bucsics, Theresa
    Krones, Elisabeth
    GASTROENTEROLOGY REPORT, 2017, 5 (02): : 127 - 137
  • [29] Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Author's reply
    Nadim, Mitra K.
    Forni, Lui G.
    Ostermann, Marlies
    INTENSIVE CARE MEDICINE, 2025, 51 (01) : 215 - 216
  • [30] Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
    Roy, Akash
    Kajal, Kamal
    Izzy, Manhal
    Sihag, Bhupendra K.
    Premkumar, Madhumita
    HEPATOLOGY, 2024, 79 (06) : E163 - E164